M.C. Bibby

1.2k total citations
39 papers, 1.0k citations indexed

About

M.C. Bibby is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, M.C. Bibby has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in M.C. Bibby's work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). M.C. Bibby is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). M.C. Bibby collaborates with scholars based in United Kingdom, Ireland and Netherlands. M.C. Bibby's co-authors include Alison Moore, John A. Double, Paul M. Loadman, J A Double, Gwendolen Rees, Roger M. Phillips, L H Patterson, T.C. Jenkins, Ian J. Stratford and Ketan C. Ruparelia and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Biology of Reproduction.

In The Last Decade

M.C. Bibby

39 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Bibby United Kingdom 17 495 283 215 155 131 39 1.0k
Klaus Memmert Switzerland 13 844 1.7× 170 0.6× 254 1.2× 182 1.2× 124 0.9× 18 1.2k
Teruhiro Utsugi Japan 20 1.2k 2.4× 423 1.5× 114 0.5× 259 1.7× 57 0.4× 85 1.8k
Hidesuke Fukazawa Japan 23 882 1.8× 329 1.2× 131 0.6× 163 1.1× 116 0.9× 50 1.6k
Danuta Duś Poland 23 776 1.6× 378 1.3× 171 0.8× 205 1.3× 56 0.4× 106 1.5k
Lisa Y. Pang United Kingdom 22 438 0.9× 382 1.3× 244 1.1× 49 0.3× 84 0.6× 36 1.2k
Kouhei Matsui Japan 18 632 1.3× 190 0.7× 156 0.7× 265 1.7× 225 1.7× 26 1.5k
Toshitaka Koga Japan 21 662 1.3× 108 0.4× 52 0.2× 244 1.6× 64 0.5× 57 1.2k
Falko Hochgräfe Germany 22 962 1.9× 192 0.7× 97 0.5× 42 0.3× 42 0.3× 35 1.4k
Zhimeng Wu China 22 1.1k 2.2× 174 0.6× 170 0.8× 235 1.5× 95 0.7× 101 1.5k
Hiroeki Sahara Japan 24 1.1k 2.2× 308 1.1× 329 1.5× 168 1.1× 77 0.6× 76 1.6k

Countries citing papers authored by M.C. Bibby

Since Specialization
Citations

This map shows the geographic impact of M.C. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Bibby more than expected).

Fields of papers citing papers by M.C. Bibby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Bibby. The network helps show where M.C. Bibby may publish in the future.

Co-authorship network of co-authors of M.C. Bibby

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Bibby. A scholar is included among the top collaborators of M.C. Bibby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Bibby. M.C. Bibby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bibby, M.C.. (2004). Orthotopic models of cancer for preclinical drug evaluation. European Journal of Cancer. 40(6). 852–857. 237 indexed citations
2.
Holwell, S E, et al.. (2003). Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.. PubMed. 22(6C). 3933–40. 42 indexed citations
3.
Stanslas, Johnson, Nadia Iftikhar, Nordin H. Lajis, et al.. (2001). Potential of AG in the treatment of breast cancer. European Journal of Cancer. 37. S169–S169. 17 indexed citations
4.
Swaine, David J., et al.. (2000). High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide. Journal of Chromatography B Biomedical Sciences and Applications. 742(2). 239–245. 14 indexed citations
5.
Ruparelia, Ketan C., L H Patterson, S. R. McKeown, et al.. (2000). True. British Journal of Cancer. 82(12). 1984–1990. 65 indexed citations
6.
Bibby, M.C.. (1999). Making the most of rodent tumour systems in cancer drug discovery. British Journal of Cancer. 79(11-12). 1633–1640. 8 indexed citations
7.
Calabrese, Christopher, Paul M. Loadman, Lee Yong Lim, et al.. (1999). In Vivo Metabolism of the Antitumor Imidazoacridinone C1311 in the Mouse and In Vitro Comparison with Humans. Drug Metabolism and Disposition. 27(2). 240–245. 11 indexed citations
8.
Jenkins, T.C., et al.. (1999). Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311. British Journal of Cancer. 81(2). 367–375. 34 indexed citations
9.
Bibby, M.C., Michael J. Thompson, Joseph A. Rafferty, Geoffrey P. Margison, & R. Stanley McElhinney. (1999). Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice. British Journal of Cancer. 79(9-10). 1332–1339. 7 indexed citations
10.
Ebrahimi, Seyed Esmaeil Sadat, M.C. Bibby, Keith R. Fox, & Kenneth T. Douglas. (1995). Synthesis, DNA binding, footprinting and in vitro antitumour studies of a meta-hydroxy analogue of Hoechst 33258.. PubMed. 10(6). 463–79. 12 indexed citations
11.
Hendriks, Hans R., Dan Berger, M.C. Bibby, et al.. (1993). EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models. European Journal of Cancer. 29(6). 897–906. 89 indexed citations
12.
Loadman, Paul M., M.C. Bibby, John A. Double, & R. Stanley McElhinney. (1992). Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model. Investigational New Drugs. 10(3). 149–158. 4 indexed citations
13.
Double, John A., M.C. Bibby, Paul M. Loadman, & J. C. Bloomer. (1988). Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations. European Journal of Cancer and Clinical Oncology. 24(8). 1355–1360. 4 indexed citations
14.
Phillips, Roger M., M.C. Bibby, & John A. Double. (1988). In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation. European Journal of Cancer and Clinical Oncology. 24(8). 1365–1371. 5 indexed citations
15.
Phillips, Roger M., M.C. Bibby, & John A. Double. (1988). Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours. Cancer Chemotherapy and Pharmacology. 21(2). 168–72. 16 indexed citations
16.
Bibby, M.C., J A Double, & Christopher M. Morris. (1988). Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours. European Journal of Cancer and Clinical Oncology. 24(8). 1361–1364. 15 indexed citations
17.
18.
Bibby, M.C., Barbara J. McDermott, John A. Double, et al.. (1987). Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours. Cancer Chemotherapy and Pharmacology. 20(3). 203–206. 4 indexed citations
19.
Double, J A, M.C. Bibby, & Paul M. Loadman. (1987). Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon. British Journal of Cancer. 54(4). 595–600. 22 indexed citations
20.
Bibby, M.C.. (1972). Population biology of the helminth parasites of Phoxinus phoxinus (L.), the minnow, in a Cardiganshire lake. Journal of Fish Biology. 4(2). 289–300. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Memmert Breakdown of academic impact, for papers by Teruhiro Utsugi Breakdown of academic impact, for papers by Hidesuke Fukazawa Breakdown of academic impact, for papers by Danuta Duś Breakdown of academic impact, for papers by Lisa Y. Pang Breakdown of academic impact, for papers by Kouhei Matsui Breakdown of academic impact, for papers by Toshitaka Koga Breakdown of academic impact, for papers by Falko Hochgräfe Breakdown of academic impact, for papers by Zhimeng Wu Breakdown of academic impact, for papers by Hiroeki Sahara
Rankless by CCL
2026